The inflammatory role of the platelet in aspirin-exacerbated respiratory disease.
血小板在阿司匹林加剧的呼吸道疾病中的炎症作用。
基本信息
- 批准号:8528709
- 负责人:
- 金额:$ 13.72万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-08-15 至 2017-07-31
- 项目状态:已结题
- 来源:
- 关键词:AdherenceAdhesionsAdultAffectAgonistAreaAspirinAsthmaAwardBiochemicalBiological AssayBiologyBiometryBloodBlood PlateletsBronchoconstrictionBronchoconstrictor AgentsCharacteristicsChronicClinicalClinical ResearchCommitComplementDataDefectDevelopment PlansDiagnosisDinoprostoneDiseaseDoseEP4 receptorEicosanoidsEnvironmentEosinophiliaFive-Year PlansFrequenciesFundingGenerationsGoalsHomeostasisHypersensitivityImmunologyIn VitroIndividualInflammationInflammatoryIngestionInvestigationIsraelKnowledgeLaboratoriesLeadLeukocyte Adhesion MoleculesLeukocyte-Adhesion ReceptorsLeukocytesLeukotriene A4Leukotriene C4Leukotriene E4LeukotrienesLifeLinkLungLung diseasesMeasuresMedicineMentorsMentorshipMolecularNasal PolypsNoseP-SelectinPathogenesisPatientsPharmaceutical PreparationsPhenotypePhysiciansPlant RootsPlatelet ActivationPopulationPositioning AttributeProductionProstaglandinsProteinsReactionReceptor SignalingRecurrenceRelative (related person)Research DesignResearch PersonnelResourcesRoleScientistSecureSeveritiesSignal TransductionSignaling ProteinSinusSinusitisSourceSyndromeTestingThromboxane A2TimeTissuesTriad Acrylic ResinUnited StatesUnited States National Institutes of HealthUp-RegulationUrineWorkWritingbasecareercareer developmentcyclooxygenase 1cyclooxygenase 2cysteinyl-leukotrienedidactic educationeosinophilexperiencegranulocytehuman WFDC2 proteinin vivoinhibitor/antagonistinsightleukocyte activationleukotriene-C4 synthasemigrationmonocyteneglectneutrophilnovelperipheral bloodpolyposispreventprostaglandin EP2 receptorpublic health relevancereceptorresearch and developmentrespiratoryresponseskillsurinary
项目摘要
DESCRIPTION (provided by applicant): This proposal details a five-year plan to provide the candidate, Tanya Laidlaw, MD, with the knowledge and expertise to become an independent investigator in the field of Allergy and Immunology. The studies focus on a previously unrecognized role for platelets as effectors of aspirin-exacerbated respiratory disease (AERD). AERD is characterized by asthma, recurrent nasal polyps, and respiratory reactions that occur upon ingestion of aspirin or other inhibitors of cyclooxygenase-1. Although the cause is unknown, the syndrome is consistently associated with tissue eosinophilia and elevated generation of cysteinyl leukotrienes, the latter of which may reflect a disturbance in the production of prostaglandin E2 or the function of its receptors (EP receptors). The candidate has discovered that platelets from individuals with AERD demonstrate decreased function of two prostaglandin E2 receptors, EP2 and EP4, which lowers the threshold for activation of their platelets and allows for increased platelet adhesion onto inflammatory granulocytes and monocytes. As a result, the blood of individuals with AERD contains substantially more platelet-leukocyte aggregates than does the blood of aspirin tolerant controls. Using a combination of cellular, biochemical, and molecular approaches, the candidate will test the hypothesis that abnormal EP2 and EP4 signaling on platelets unifies the phenomena of leukotriene overproduction, tissue eosinophilia, and aspirin-induced reactions in patients with AERD. The results from these studies will advance our understanding of the pathogenesis of AERD. During the period of support the candidate will complement her laboratory skills with didactic coursework to develop skills in clinical study design, advanced biostatistics, and scientific writing. This will then facilitate her transition to independence during the third and fourth yearsof the award. Dr. Laidlaw will work under the mentorship of Joshua Boyce, MD, an expert in eicosanoid biology and mechanisms of inflammation, who has an excellent record of mentoring young investigators for successful careers in academic medicine. Dr. Laidlaw has also assembled a team of extraordinary physician scientists, including Drs. Elliot Israel, Mariana Castells, and K. Frank Austen, who have committed their time, resources, and expertise to facilitate her career development and research goals. Under their mentorship and guidance, in an ideal scientific and clinical environment at the BWH, the translational work, didactic curriculum, and career development plan will position the candidate to secure independent NIH funding and to establish herself as a physician scientist with a focus on AERD, a relatively neglected area of investigation.
描述(由申请人提供):该提案详细介绍了为候选人Tanya Laidlaw,医学博士提供的五年计划,并提供了成为过敏和免疫学领域的独立研究者的知识和专业知识。这些研究集中在血小板作为阿司匹林诊断呼吸道疾病(AERD)的作用方面的作用。 AERD的特征是哮喘,复发性鼻息肉以及摄入阿司匹林或其他环氧酶-1抑制剂后发生的呼吸反应。尽管原因尚不清楚,但该综合征一直与组织嗜酸性粒细胞和白细胞三烯的产生升高有关,后者可能反映了前列腺素E2或其受体功能的干扰(EP受体)。该候选人发现,来自AERD个体的血小板表明,两个前列腺素E2受体EP2和EP4的功能降低,这降低了其血小板的阈值,并允许增加血小板上对炎症性颗粒细胞和单核细胞的粘附增加。结果,与阿司匹林耐受对照的血液相比,AERD个体的血液含有大得多的血小板 - 白细胞骨料。使用细胞,生化和分子方法的结合,候选者将测试血小板上异常EP2和EP4信号的假设,可以统一白细胞过量产生,组织嗜酸性粒细胞嗜酸性粒细胞和阿司匹林诱导的AERD患者反应的现象。这些研究的结果将提高我们对AERD发病机理的理解。在支持期间,候选人将通过教学课程来补充她的实验室技能,以发展临床研究设计,高级生物统计学和科学写作方面的技能。然后,这将促进她在该奖项的第三年和第四年过渡到独立性。 Laidlaw博士将在eicosanoid生物学和炎症机制的专家Joshua Boyce的指导下工作,后者在指导年轻研究人员的学术医学职业方面有着良好的记录。 Laidlaw博士还召集了包括Drs在内的非凡医师科学家团队。以色列,玛丽安娜·卡斯特尔(Mariana Castells)和K. Frank Austen致力于促进她的职业发展和研究目标。在他们的指导和指导下,在BWH的理想科学和临床环境中,翻译工作,教学课程和职业发展计划将使候选人确保获得独立的NIH资助,并确立自己的医生科学家,重点关注AERD,这是一个相对忽视的研究领域。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Tanya Maria Laidlaw其他文献
Tanya Maria Laidlaw的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Tanya Maria Laidlaw', 18)}}的其他基金
Prostaglandin D2: A Key Mediator of Aspirin-Exacerbated Respiratory Disease
前列腺素 D2:阿司匹林加重呼吸系统疾病的关键介质
- 批准号:
9332401 - 财政年份:2015
- 资助金额:
$ 13.72万 - 项目类别:
The inflammatory role of the platelet in aspirin-exacerbated respiratory disease.
血小板在阿司匹林加剧的呼吸道疾病中的炎症作用。
- 批准号:
8703167 - 财政年份:2012
- 资助金额:
$ 13.72万 - 项目类别:
The inflammatory role of the platelet in aspirin-exacerbated respiratory disease.
血小板在阿司匹林加剧的呼吸道疾病中的炎症作用。
- 批准号:
8374246 - 财政年份:2012
- 资助金额:
$ 13.72万 - 项目类别:
Project 3. Mechanisms of benefit of biologic agents for patients with aspirin-exacerbated respiratory disease (AERD)
项目3.生物制剂对阿司匹林急性呼吸道疾病(AERD)患者的获益机制
- 批准号:
10626855 - 财政年份:2011
- 资助金额:
$ 13.72万 - 项目类别:
Project 3. Mechanisms of benefit of biologic agents for patients with aspirin-exacerbated respiratory disease (AERD)
项目3.生物制剂对阿司匹林急性呼吸道疾病(AERD)患者的获益机制
- 批准号:
10260785 - 财政年份:2011
- 资助金额:
$ 13.72万 - 项目类别:
Project 3. Mechanisms of benefit of biologic agents for patients with aspirin-exacerbated respiratory disease (AERD)
项目3.生物制剂对阿司匹林急性呼吸道疾病(AERD)患者的获益机制
- 批准号:
10456246 - 财政年份:2011
- 资助金额:
$ 13.72万 - 项目类别:
相似国自然基金
促细胞外囊泡分泌的绒毛膜纳米纤维仿生培养体系的构建及其在宫腔粘连修复中的应用研究
- 批准号:32301204
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
载Pexidartinib的纳米纤维膜通过阻断CSF-1/CSF-1R通路抑制巨噬细胞活性预防心脏术后粘连的研究
- 批准号:82370515
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
泛素连接酶SMURF2通过SMAD6-COL5A2轴调控宫腔粘连纤维化的分子机制研究
- 批准号:82360301
- 批准年份:2023
- 资助金额:31 万元
- 项目类别:地区科学基金项目
负载羟基喜树碱的双层静电纺纳米纤维膜抑制肌腱粘连组织增生的作用和相关机制研究
- 批准号:82302691
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
膜仿生载基因纳米球体内重编程巨噬细胞抑制肌腱粘连的机制研究
- 批准号:82372389
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Sustained delivery technology for Cyclosporine A in the treatment of autoimmune response
环孢素 A 持续递送技术治疗自身免疫反应
- 批准号:
10256580 - 财政年份:2021
- 资助金额:
$ 13.72万 - 项目类别:
Understanding the pathophysiology of GBS UTI in diabetes
了解糖尿病 GBS UTI 的病理生理学
- 批准号:
10348280 - 财政年份:2021
- 资助金额:
$ 13.72万 - 项目类别:
Understanding the pathophysiology of GBS UTI in diabetes
了解糖尿病 GBS UTI 的病理生理学
- 批准号:
10495253 - 财政年份:2021
- 资助金额:
$ 13.72万 - 项目类别:
Blood Brain Barrier Disruption during Chimeric Antigen Receptor (CAR) T cell therapy
嵌合抗原受体 (CAR) T 细胞治疗期间的血脑屏障破坏
- 批准号:
10480869 - 财政年份:2020
- 资助金额:
$ 13.72万 - 项目类别:
Blood Brain Barrier Disruption during Chimeric Antigen Receptor (CAR) T cell therapy
嵌合抗原受体 (CAR) T 细胞治疗期间的血脑屏障破坏
- 批准号:
10039479 - 财政年份:2020
- 资助金额:
$ 13.72万 - 项目类别: